Price T Rowe Associates Inc. MD Has $333.60 Million Stock Holdings in The Cooper Companies, Inc. $COO

Key Points

• Price T Rowe Associates Inc. MD increased its stake in The Cooper Companies by 12.1%, acquiring an additional 425,400 shares, bringing its total ownership to about 3.95 million shares worth approximately $333.6 million.
• Several hedge funds also acquired new positions or significantly increased their holdings in The Cooper Companies during the first quarter, indicating strong interest from institutional investors.
• Recent analyst reports have resulted in a mix of ratings for the stock, with Needham & Company upgrading it to a "buy" and BNP Paribas assigning a "strong-buy" rating, while others have set lower price targets.

Price T Rowe Associates Inc. MD lifted its holdings in The Cooper Companies, Inc. (NASDAQ:COO - Free Report) by 12.1% in the 1st quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 3,954,877 shares of the medical device company's stock after buying an additional 425,400 shares during the period. Price T Rowe Associates Inc. MD owned about 1.98% of Cooper Companies worth $333,595,000 as of its most recent SEC filing.

A number of other hedge funds have also made changes to their positions in the stock. Guggenheim Capital LLC grew its holdings in shares of Cooper Companies by 33.1% during the 4th quarter. Guggenheim Capital LLC now owns 6,808 shares of the medical device company's stock valued at $626,000 after acquiring an additional 1,694 shares in the last quarter. Dimensional Fund Advisors LP grew its stake in Cooper Companies by 8.4% in the fourth quarter. Dimensional Fund Advisors LP now owns 1,558,158 shares of the medical device company's stock valued at $143,234,000 after purchasing an additional 120,330 shares in the last quarter. MML Investors Services LLC increased its position in Cooper Companies by 3.5% in the 4th quarter. MML Investors Services LLC now owns 18,403 shares of the medical device company's stock worth $1,692,000 after purchasing an additional 616 shares during the last quarter. Pinebridge Investments L.P. acquired a new position in Cooper Companies in the 4th quarter worth about $2,633,000. Finally, MGO One Seven LLC raised its stake in shares of Cooper Companies by 7.2% during the 4th quarter. MGO One Seven LLC now owns 3,924 shares of the medical device company's stock worth $361,000 after purchasing an additional 264 shares in the last quarter. 24.39% of the stock is owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

A number of research firms recently commented on COO. JPMorgan Chase & Co. restated a "neutral" rating and issued a $76.00 price objective (down previously from $110.00) on shares of Cooper Companies in a report on Friday, May 30th. Wall Street Zen downgraded shares of Cooper Companies from a "buy" rating to a "hold" rating in a research report on Saturday, July 12th. BNP Paribas upgraded shares of Cooper Companies from a "hold" rating to a "strong-buy" rating in a report on Tuesday, July 22nd. Mizuho decreased their price objective on shares of Cooper Companies from $105.00 to $90.00 and set an "outperform" rating for the company in a report on Wednesday, July 16th. Finally, Loop Capital set a $100.00 target price on Cooper Companies in a report on Tuesday, June 17th. One investment analyst has rated the stock with a Strong Buy rating, nine have issued a Buy rating and two have issued a Hold rating to the company's stock. According to data from MarketBeat.com, Cooper Companies currently has a consensus rating of "Moderate Buy" and a consensus price target of $96.73.

Cooper Companies Stock Performance

COO traded up $0.18 during midday trading on Tuesday, reaching $73.66. The company's stock had a trading volume of 4,307,279 shares, compared to its average volume of 1,627,738. The stock has a market cap of $14.73 billion, a P/E ratio of 35.76, a PEG ratio of 1.79 and a beta of 1.00. The company has a fifty day simple moving average of $72.35 and a 200 day simple moving average of $77.91. The company has a current ratio of 2.10, a quick ratio of 1.23 and a debt-to-equity ratio of 0.30. The Cooper Companies, Inc. has a twelve month low of $65.00 and a twelve month high of $112.38.

Cooper Companies (NASDAQ:COO - Get Free Report) last released its earnings results on Thursday, May 29th. The medical device company reported $0.96 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.93 by $0.03. The firm had revenue of $1 billion for the quarter, compared to analyst estimates of $995.12 million. Cooper Companies had a return on equity of 9.60% and a net margin of 10.39%.The company's revenue was up 6.3% on a year-over-year basis. During the same quarter last year, the firm posted $0.85 EPS. Cooper Companies has set its FY 2025 guidance at 4.050-4.110 EPS. Research analysts expect that The Cooper Companies, Inc. will post 3.98 earnings per share for the current year.

Cooper Companies Company Profile

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.